Cargando…
Gemcitabine-Induced Myositis in a Luminal B Breast Cancer patient: A Case Report
Human epidermal growth factor receptor-positive breast cancer is an aggressive cancer which represents approximately a quarter of all breast cancers worldwide. Recent advances have led to the development of targeted therapies, such as trastuzumab (H), which have significantly improved prognosis. Suc...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941597/ https://www.ncbi.nlm.nih.gov/pubmed/36824292 http://dx.doi.org/10.1177/11795476231156290 |